juvenile dermatomyositis: Juvenile dermatomyositis (JDM) is the early-onset form of dermatomyositis (DM, see this term), a systemic, autoimmune inflammatory muscle disorder, characterized by proximal muscle weakness, evocative skin lesion, and systemic manifestations.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
517 |
6. Filter based on genotype QC (FinnGen only) |
517 |
Control definitions (FinnGen only)
- Control exclude
- RHEUMA_ENDPOINTS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Dermatopolymyositis (FG)
based on the number of shared cases.
Similar with more cases:
- Dermatopolymyositis
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
- Autoimmune diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3476 | 2143 | 1288 |
| Only index persons | 2514 | 1586 | 928 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.06 | 0.04 |
| Only index persons | 0.05 | 0.06 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 59.02 | 59.14 | 58.69 |
| Only index persons | 55.63 | 55.68 | 55.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 517 | 320 | 197 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.09 |
| Median age at first event (years) | 55.30 | 53.71 | 57.88 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 477
- Matched controls
- 4770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M33.2
ICD-10 Finland
Polymyositis
+∞
276.9
238
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
101.4
244.1
259
55
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
+∞
190.8
170
*
M33.1
ICD-10 Finland
Other dermatomyositis
+∞
171.5
154
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
80.6
170.6
188
38
P01BA02
ATC
hydroxychloroquine; oral
59.2
132.2
154
38
L04AX01
ATC
azathioprine; systemic
37.8
115.1
148
56
M60.9
ICD-10 Finland
Myositis, unspecified
446.9
107.9
104
*
H02AB06
ATC
prednisolone; systemic
9.7
104.7
380
1375
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.5
89.3
312
962
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
44.7
76.5
94
26
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
+∞
71.7
67
*
G72.9
ICD-10 Finland
Myopathy, unspecified
112.7
71.3
76
8
M05BA04
ATC
alendronic acid; oral
11.7
66.1
131
149
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
13.2
65.1
121
120
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
129.5
63.7
67
6
NXL00
NOMESCO Finland
Biopsy of muscle
177.6
60.5
62
*
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
161.3
55.2
57
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
27.1
50.6
70
30
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
278.4
50.1
50
*
M60.8
ICD-10 Finland
Other myositis
504.6
47.1
46
*
H02AB07
ATC
prednisone; oral
6.1
46.8
146
322
L88
ICPC
Rheumatoid/seropositive arthritis
111.4
46.8
50
5
L04AA06
ATC
mycophenolic acid; systemic
28.5
42.7
58
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
42.0
275
1248
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
6.9
41.3
112
202
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
82.3
40.7
45
6
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
149.1
39.4
41
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
35.9
34
*
M13.9
ICD-10 Finland
Arthritis, unspecified
24.1
33.8
48
22
L04AD01
ATC
ciclosporin; systemic
24.7
33.4
47
21
M17.1
ICD-10 Finland
Other primary gonarthrosis
9.0
32.0
70
89
M35.1
ICD-10 Finland
Other overlap syndromes
+∞
29.5
28
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.2
29.3
68
95
L04AA01
ATC
[U] ciclosporin; systemic
30.7
28.0
37
13
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
9.8
25.8
53
60
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
25.2
24
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
24.7
185
828
M05BA07
ATC
risedronic acid; oral
9.8
23.4
48
54
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
23.1
22
*
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
22.0
21
*
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
120.5
21.8
23
*
L99
ICPC
Musculoskeletal disease other
22.0
21.5
31
15
A02BC02
ATC
pantoprazole; systemic
2.6
21.5
332
2220
7104A
ICD-9 Finland
Diffuse diseases of connective tissue, Polymyositis
+∞
21.0
20
*
M33.0
ICD-10 Finland
Juvenile dermatomyositis
219.1
20.7
21
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
19.4
20.7
31
17
R50.9
ICD-10 Finland
Fever, unspecified
3.7
20.6
98
308
C03CA01
ATC
furosemide; systemic
2.8
20.4
169
783
L28
ICPC
Limited function/disability (L)
3.7
20.0
97
310
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
19.9
19
*
71610
ICD-8 Finland
Polymyositis and dermatomyositis, Polymyositis
+∞
19.9
19
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
48.1
19.4
23
5
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
12.1
19.3
35
31
R4110
NOMESCO Finland
Physiotherapy
2.8
19.1
154
701
L04AA13
ATC
leflunomide; oral
197.4
18.7
19
*
ZX120
NOMESCO Finland
Intravenous
4.1
18.6
77
213
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
45.9
18.4
22
5
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
13.2
17.9
31
25
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.1
17.8
108
406
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.2
17.8
37
43
XX9XE
NOMESCO Finland
Other ultrasound examination
186.6
17.6
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
17.6
125
521
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
17.4
145
667
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
17.0
93
323
TGC00
NOMESCO Finland
Bronchial lavation
10.3
16.9
33
34
N03AX16
ATC
pregabalin; oral
2.8
16.7
129
564
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.7
16.2
56
130
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
20.1
15.7
23
12
R13
ICD-10 Finland
Dysphagia
4.5
15.6
57
140
JN4BD
NOMESCO Finland
Extensive body CT
3.5
15.6
79
259
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.6
15.4
73
226
A07EC01
ATC
sulfasalazine; oral, rectal
7.9
15.0
34
46
R06.0
ICD-10 Finland
Dyspnoea
2.5
14.8
139
675
71600
ICD-8 Finland
Polymyositis and dermatomyositis, Dermatomyositis
+∞
14.7
14
*
NF1AA
NOMESCO Finland
Hip X-ray examination
6.7
14.6
37
59
G72.8
ICD-10 Finland
Other specified myopathies
11.9
14.4
26
23
XG410
NOMESCO Finland
Flow-volume spirometry
5.9
14.3
40
73
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.9
14.0
60
171
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
18.2
13.9
21
12
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
5.9
13.9
39
71
H26.3
ICD-10 Finland
Drug-induced cataract
55.0
13.9
16
*
XPX04
NOMESCO Finland
Angioscopy
77.4
13.6
15
*
M33
ICD-10 Finland
Dermatopolymyositis
+∞
13.6
13
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
13.6
13
*
7103B
ICD-9 Finland
Diffuse diseases of connective tissue, Dermatomyositis[DERMATOMYOSITIS ADULTORUM]
+∞
13.6
13
*
R4120
NOMESCO Finland
Occupational therapy
4.4
13.2
49
122
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
13.0
103
450
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.4
13.0
66
216
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
12.9
117
551
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
51.5
12.9
15
*
1XC02
NOMESCO Finland
NA
51.5
12.9
15
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
7.8
12.9
29
39
L19
ICPC
Muscle symptom/complaint NOS
7.6
12.7
29
40
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
12.5
12
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
12.4
52
145
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.8
12.4
54
156
E0000UV
ATC
NA
2.1
12.3
197
1207
C08CA05
ATC
nifedipine; systemic
4.1
12.3
49
131
B01AB05
ATC
enoxaparin; parenteral
2.3
12.3
132
678
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
27.5
12.1
16
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
12.1
182
1083
XA402
NOMESCO Finland
ENMG
6.7
12.1
30
47
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
12.0
141
750
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
11.7
116
569
318
Kela drug reimbursment
Teriparatide
66.6
11.7
13
*
H05AA02
ATC
teriparatide; parenteral
66.6
11.7
13
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
66.6
11.7
13
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.2
11.5
64
222
S18
ICPC
Laceration/cut
2.0
11.5
193
1193
N02AX02
ATC
tramadol; systemic, rectal
2.0
11.5
190
1167
A07AA02
ATC
nystatin; oral
3.9
11.5
48
134
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
11.2
55
175
M25.5
ICD-10 Finland
Pain in joint
2.2
11.1
128
675
D07AC01
ATC
betamethasone; topical
2.0
10.8
171
1029
D07AB08
ATC
desonide; topical
2.9
10.8
67
252
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
18.3
10.8
16
9
5BA08
NOMESCO Finland
NA
61.4
10.7
12
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.1
10.6
61
218
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
10.6
144
812
J01FF01
ATC
clindamycin; systemic
2.2
10.6
130
702
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.7
10.5
46
134
M81.4
ICD-10 Finland
Drug-induced osteoporosis
112.3
10.5
11
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
112.3
10.5
11
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.8
10.4
44
124
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.9
10.4
42
114
A02BC01
ATC
omeprazole; systemic
2.1
10.3
139
780
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.6
10.3
29
54
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
10.2
79
338
J05AB01
ATC
aciclovir; systemic
2.2
10.2
111
567
A02BC05
ATC
esomeprazole; systemic
1.9
10.1
194
1251
M79.1
ICD-10 Finland
Myalgia
2.8
10.0
69
276
M05BX04
ATC
denosumab; parenteral
4.5
10.0
35
83
Z50.1
ICD-10 Finland
Other physical therapy
4.2
10.0
37
93
J01DB01
ATC
cefalexin; oral
2.0
9.9
373
3044
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.8
9.9
32
70
N06AA09
ATC
amitriptyline; systemic
3.1
9.8
55
192
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
13.7
9.7
16
12
M16.1
ICD-10 Finland
Other primary coxarthrosis
8.1
9.7
21
27
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
56.1
9.7
11
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
6.6
9.7
24
38
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
9.6
31
68
WZA10
NOMESCO Finland
Long statement of health and health related matters
15.4
9.6
15
10
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
9.5
49
163
A28
ICPC
Limited function/disability NOS
2.5
9.5
75
326
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
9.5
200
1326
M62.9
ICD-10 Finland
Disorder of muscle, unspecified
30.7
9.4
12
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
+∞
9.4
9
*
212
Kela drug reimbursment
Gout
+∞
9.4
9
*
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
22.2
9.4
13
6
H02AB04
ATC
methylprednisolone; systemic
2.5
9.4
79
353
XQ848
NOMESCO Finland
Dermatological photography
6.7
9.4
23
36
M48.0
ICD-10 Finland
Spinal stenosis
2.9
9.2
58
220
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.2
9.1
27
54
L93.0
ICD-10 Finland
Discoid lupus erythematosus
37.4
9.0
11
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.8
9.0
60
235
N02AA05
ATC
oxycodone; systemic
2.5
8.9
71
308
RF420
NOMESCO Finland
NA
11.0
8.8
16
15
UJF32
NOMESCO Finland
Coloscopy
2.0
8.6
125
715
TNG10
NOMESCO Finland
Puncture of knee
28.1
8.5
11
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
13.1
8.4
14
11
R52.2
ICD-10 Finland
Other chronic pain
5.4
8.4
24
46
D07AC13
ATC
mometasone; topical
1.9
8.4
140
846
N28
ICPC
Limited function/disability (N)
8.8
8.4
17
20
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
8.4
8
*
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
+∞
8.4
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
8.3
52
196
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
8.3
44
150
C07AB07
ATC
bisoprolol; oral
1.8
8.2
219
1545
M01AH01
ATC
celecoxib; oral (coxibs)
2.3
8.2
77
363
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
8.2
81
391
SPAT1229
SPAT
Assessment of need for aid
3.1
8.1
44
152
N03AX12
ATC
gabapentin; oral
2.4
8.1
71
324
SPAT1216
SPAT
Assessment of functional ability
2.4
7.9
70
319
RF410
NOMESCO Finland
NA
13.3
7.9
13
10
R53
ICD-10 Finland
Malaise and fatigue
2.1
7.9
100
542
WX002
NOMESCO Finland
Sedation and analgesia
2.2
7.8
88
453
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
11.0
7.8
14
13
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.2
7.8
23
46
M01AH02
ATC
rofecoxib; oral
2.5
7.7
62
271
WX320
NOMESCO Finland
Spinalanesthesy
2.2
7.7
81
404
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
45.7
7.7
9
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
6.3
7.6
19
31
M05BA01
ATC
etidronic acid; systemic
25.5
7.6
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
7.6
126
756
A01AB09
ATC
miconazole; local oral
2.7
7.6
52
209
J01DA01
ATC
[U] cefalexin; systemic
1.7
7.5
289
2254
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
7.5
149
950
R1250
NOMESCO Finland
Evaluation of functional capability
6.6
7.5
18
28
M79.6
ICD-10 Finland
Pain in limb
1.8
7.5
149
951
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
81.3
7.4
8
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
81.3
7.4
8
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
81.3
7.4
8
*
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
81.3
7.4
8
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
7.4
77
383
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.1
7.4
22
45
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
+∞
7.3
7
*
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
7.3
7
*
M31.1
ICD-10 Finland
Thrombotic microangiopathy
+∞
7.3
7
*
6BA02
NOMESCO Finland
NA
+∞
7.3
7
*
M04AA01
ATC
allopurinol; systemic
2.6
7.3
53
219
M05BB03
ATC
alendronic acid and colecalciferol; oral
5.6
7.3
20
37
E000001
ATC
NA
2.0
7.2
102
575
M13.0
ICD-10 Finland
Polyarthritis, unspecified
30.5
7.2
9
*
NG1DA
NOMESCO Finland
X-ray of knees
20.4
7.2
10
5
N99
ICPC
Neurological disease other
9.0
7.1
14
16
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.4
7.1
33
103
M01AX01
ATC
nabumetone; oral
4.4
7.0
24
57
R4190
NOMESCO Finland
Nutritional therapy
4.2
7.0
25
62
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
4.2
7.0
25
62
GD1AD
NOMESCO Finland
Thorax CT examination
4.0
7.0
26
67
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.0
7.0
18
31
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
7.0
73
361
A02BC03
ATC
lansoprazole; oral
1.8
6.9
143
923
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
6.9
131
820
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.3
6.9
62
289
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
6.8
45
177
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
6.8
99
562
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.8
6.8
138
881
XG466
NOMESCO Finland
Sleep oxymetry
4.2
6.8
24
59
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
40.6
6.8
8
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
40.6
6.8
8
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
22.9
6.7
9
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.8
6.7
27
75
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
6.7
122
752
M79.7
ICD-10 Finland
Fibromyalgia
6.0
6.7
17
29
L29
ICPC
Musculoskeletal sympt/complt other
2.8
6.7
42
159
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
6.6
49
205
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.5
6.6
22
51
J02AC01
ATC
fluconazole; systemic
1.7
6.6
178
1237
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
4.9
6.6
20
42
RF120
NOMESCO Finland
NA
10.2
6.6
12
12
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
10.2
6.6
12
12
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
6.6
59
272
RF210
NOMESCO Finland
NA
5.5
6.5
18
34
J01MA12
ATC
levofloxacin; systemic
2.0
6.5
86
471
M05BA06
ATC
ibandronic acid; systemic
6.3
6.5
16
26
SPAT1262
SPAT
Handing over of treatment supplies
2.0
6.5
84
455
C08CA01
ATC
amlodipine; oral
1.7
6.5
161
1092
SPAT1153
SPAT
Removal of sutures
1.8
6.4
132
844
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
70.7
6.4
7
*
M60.0
ICD-10 Finland
Infective myositis
70.7
6.4
7
*
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
70.7
6.4
7
*
L18
ICPC
Muscle pain
5.0
6.4
19
39
ZXA00
NOMESCO Finland
Right side
1.8
6.4
115
703
I50.9
ICD-10 Finland
Heart failure, unspecified
2.2
6.4
61
292
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
6.4
159
1079
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
11.2
6.3
11
10
NG2AA
NOMESCO Finland
Patella X-ray examination
18.3
6.3
9
5
ZX140
NOMESCO Finland
Intra articular
+∞
6.3
6
*
M34.1
ICD-10 Finland
CR(E)ST syndrome
+∞
6.3
6
*
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
6.3
6
*
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
6.3
6
*
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
27.0
6.2
8
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.6
6.2
26
75
J05AB11
ATC
valaciclovir; oral
2.2
6.2
64
317
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.8
6.2
37
138
ZXA05
NOMESCO Finland
Left side
1.8
6.1
110
673
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.1
72
378
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
12.7
6.1
10
8
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
12.7
6.1
10
8
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
8.8
6.1
12
14
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.6
6.1
42
168
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
10.2
6.1
11
11
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
6.0
49
217
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
155
113
19.16
175.80
6.0
2.1
ug/l
556.2
699.2
0.12
150
105
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
380
1118
10.05
142.48
12.1
2.0
u/l
240.3
328.3
0.49
375
1063
(3037522) Nuclear Ab [Titer] in Serum
229
395
9.61
141.06
1.9
1.2
titre
697.8
331.1
3.87
101
79
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
104
60
21.45
130.96
1.7
1.1
u/ml
50.0
—
—
10
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
107
90
14.73
109.88
2.2
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
110
8
174.07
107.92
1.4
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
94
79
14.32
96.17
1.6
1.1
u/ml
12.4
5.7
—
25
8
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
93
79
14.13
94.48
1.6
1.1
u/ml
1.8
2.9
—
13
7
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
67
13.53
78.30
1.5
1.5
iu/ml
300.1
0.2
0.47
11
11
(3001604) Monocytes [#/volume] in Blood
390
1811
5.70
71.22
16.8
4.7
e9/l
0.6
0.6
0.19
375
1540
(3006315) Basophils [#/volume] in Blood
391
1821
5.71
71.09
16.9
4.7
e9/l
0.0
0.0
0.68
375
1548
(42870588) Differential panel, method unspecified - Blood
310
1209
4.91
70.69
15.2
4.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
392
1874
5.52
67.67
16.9
4.7
e9/l
1.7
2.0
3.71
381
1630
(3022096) Basophils/100 leukocytes in Blood
366
1665
5.10
67.17
16.8
4.7
%
0.7
0.7
0.08
359
1542
(3013115) Eosinophils [#/volume] in Blood
392
1887
5.46
66.70
17.3
5.1
e9/l
0.2
0.2
3.14
381
1641
(3006504) Eosinophils/100 leukocytes in Blood
371
1716
5.11
66.33
17.2
4.7
%
2.6
2.9
2.69
363
1584
(3019069) Monocytes/100 leukocytes in Blood
372
1725
5.12
66.27
17.8
4.9
%
8.8
8.7
0.30
366
1604
(3018010) Neutrophils/100 leukocytes in Blood
369
1749
4.88
62.52
16.8
4.7
%
59.4
56.7
4.05
363
1631
(3002030) Lymphocytes/100 leukocytes in Blood
372
1777
4.90
62.30
17.2
4.8
%
26.0
28.2
3.79
366
1651
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
44
20
23.95
60.27
1.4
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
405
2184
4.94
54.59
19.5
8.7
e9/l
4.2
4.0
0.91
389
1888
(3004616) Nuclear Ab [Presence] in Serum
42
33
13.76
43.95
1.7
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
126
353
4.40
41.47
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
96
231
4.88
38.10
1.3
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
117
331
4.28
37.77
1.8
2.2
nmol/l
352.2
396.3
0.59
110
310
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
138
448
3.84
36.67
1.5
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
33
24
14.62
35.95
2.0
2.0
e9/l
0.9
1.3
0.70
21
13
(3007164) IgA [Mass/volume] in Serum or Plasma
183
741
3.27
34.13
2.0
1.4
g/l
2.2
2.4
0.65
142
426
(3004588) Protein electrophoresis panel - Serum or Plasma
91
229
4.61
34.00
2.9
3.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
94
244
4.49
33.76
7.4
3.9
%
0.0
0.1
0.60
34
60
(3013707) Erythrocyte sedimentation rate by Westergren method
428
2830
3.98
33.75
12.9
3.1
mm/h
15.0
11.6
5.03
417
2565
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
318
1772
3.06
33.50
10.5
5.5
mmol/l
1.2
1.2
0.20
303
1587
(3017181) Myelocytes/100 leukocytes in Blood
102
288
4.17
32.73
7.4
3.8
%
0.8
1.1
0.80
39
81
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
333
1932
3.03
32.07
12.1
6.3
mmol/l
1.2
1.2
0.18
291
1620
(3021788) Differential panel - Synovial fluid
25
13
20.16
32.01
1.4
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
25
15
17.46
29.96
2.2
2.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
285
1569
2.82
29.43
3.2
2.2
nmol/l
76.9
78.5
0.43
269
1384
(3021440) Promyelocytes/100 leukocytes in Blood
93
267
4.03
28.99
7.7
3.8
%
0.1
0.2
0.87
37
71
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
18
15.16
28.97
2.2
1.9
%
18.6
11.4
—
14
9
(3018418) pH of Serum or Plasma
233
1163
2.83
28.97
5.9
4.0
ph
7.4
7.4
0.90
40
215
(3002179) Metamyelocytes/100 leukocytes in Blood
91
262
4.00
28.22
6.7
3.7
%
0.8
0.7
0.16
30
59
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
27
21
13.51
28.20
1.6
1.1
u/ml
2.2
—
—
5
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
27
24
11.81
25.98
1.6
1.1
u/ml
103.5
—
—
8
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
125
5.10
25.90
3.0
2.7
g/l
3.1
3.0
0.40
51
101
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
123
5.08
25.41
3.0
2.7
g/l
10.3
10.6
0.12
51
108
(3037467) Urinalysis macro (dipstick) panel - Urine
391
2649
2.95
25.32
8.8
3.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
68
6.63
25.29
10.0
6.3
iu/ml
519.6
213.4
—
9
13
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
132
4.92
25.21
3.0
2.7
g/l
3.5
3.5
0.06
50
100
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
132
4.92
25.21
3.0
2.7
g/l
7.2
6.9
0.62
52
102
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
59
132
4.92
25.21
3.0
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
244
1336
2.56
24.08
5.2
3.4
e6/l
111.8
102.4
0.05
178
952
(3035350) Ketones [Presence] in Urine by Test strip
305
1858
2.56
23.92
5.4
3.3
estimate
0.0
0.0
0.00
61
338
(40758558) Short blood count panel - Blood
191
949
2.61
22.85
13.7
6.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
305
1888
2.50
22.66
5.5
3.4
estimate
0.0
0.0
0.80
65
332
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
130
536
2.90
22.34
1.4
1.2
iu/ml
61.7
17.9
1.59
42
159
(3023368) Bacteria identified in Blood by Culture
196
997
2.56
22.21
6.1
3.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
56
134
4.57
22.00
3.2
2.9
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
49
105
5.05
21.97
3.3
2.7
g/l
0.0
0.1
0.50
49
98
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
140
607
2.79
21.85
2.3
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
301
1877
2.44
21.63
7.2
4.8
estimate
0.0
0.0
0.50
64
339
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
26
10.05
21.60
2.4
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
209
1115
2.47
21.18
4.6
2.8
ng/l
1091.4
1251.7
0.34
192
938
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
47
101
5.02
20.99
3.4
2.7
g/l
0.0
0.0
0.00
47
94
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
47
101
5.02
20.99
3.4
2.7
g/l
0.0
0.0
0.00
47
94
(3012095) Magnesium [Moles/volume] in Serum or Plasma
140
621
2.72
20.79
6.5
3.1
mmol/l
0.8
0.8
0.86
132
586
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
33
8.58
20.68
1.5
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
114
464
2.87
19.87
2.1
1.4
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
273
1673
2.34
19.83
7.3
4.4
g/l
34.0
35.7
4.76
264
1552
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
11
15.95
19.43
1.4
1.0
%
12.2
83.8
—
9
6
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
42
89
5.05
19.04
1.8
1.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
114
474
2.80
19.03
2.9
2.3
%
23.1
23.9
0.20
99
409
(40760892) CBC W Ordered Manual Differential panel - Blood
160
793
2.47
18.64
9.5
4.1
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
16
10
16.48
18.58
2.6
2.2
%
6.6
9.6
—
11
10
(3021589) Normoblasts [#/volume] in Blood
277
1742
2.27
18.49
20.6
8.0
e9/l
0.0
0.0
0.30
250
1407
(3000475) Leukocytes [#/volume] in Synovial fluid
22
24
9.53
18.32
1.7
1.1
e6/l
4675.6
16086.8
0.72
16
17
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
83
296
3.15
18.20
4.4
3.1
ng/l
186.0
199.8
0.13
75
280
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
97
4.74
18.11
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
35
66
5.62
18.03
1.5
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
73
244
3.32
17.80
2.4
2.5
au/ml
11.3
15.8
—
5
13
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
56
6.03
17.80
1.2
1.9
g/l
0.4
0.8
1.00
25
46
(3000850) Epithelial cells [#/volume] in Urine
155
772
2.44
17.75
3.2
2.3
e6/l
3.0
6.3
2.42
141
679
(40768443) Skin Pathology biopsy report
60
178
3.68
17.56
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
41
92
4.75
17.37
1.9
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
34
65
5.53
17.25
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
191
1059
2.27
16.95
4.4
2.8
e6/l
0.3
0.6
2.07
154
787
(36304419) Bacteria [Presence] in Urine
187
1028
2.28
16.94
4.4
2.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
59
5.72
16.87
1.4
1.4
u/ml
96.3
112.3
—
6
7
(4035726)
94
376
2.83
16.74
1.3
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
33
64
5.44
16.49
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
113
501
2.61
16.44
1.3
1.2
u/ml
33.8
3.5
1.01
33
191
(3002582) Erythrocytes [#/volume] in Urine
203
1168
2.22
16.34
4.3
2.9
e6/l
79.2
66.7
0.07
168
891
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
59
5.53
15.80
1.3
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31
60
5.43
15.51
1.2
1.2
u/ml
299.6
226.0
0.53
21
31
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
64
5.26
15.45
1.8
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
22
8.93
15.10
2.1
2.3
e6/l
924.7
521.1
—
7
9
(3026493) Urate [Moles/volume] in Serum or Plasma
162
876
2.24
14.97
4.0
2.5
umol/l
2731.6
10265.1
1.77
149
748
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
213
1283
2.12
14.96
6.1
3.0
u/l
48.6
33.0
2.54
203
1212
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
128
627
2.38
14.91
3.5
2.5
e6/l
0.7
1.0
1.60
85
338
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
161
871
2.23
14.84
2.7
1.9
mg/l
3.3
3.1
0.34
144
723
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
99
434
2.58
14.63
2.2
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
154
823
2.24
14.59
5.7
3.3
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
20
26
7.96
14.51
1.2
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
20
26
7.96
14.51
1.2
1.2
titre
61.3
110.0
—
8
5
(3007853) Bacteria identified in Skin by Aerobe culture
91
386
2.65
14.36
2.1
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
104
473
2.50
14.20
8.7
4.9
mmol/l
1.0
1.0
0.19
99
438
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
29
58
5.24
14.00
5.1
2.9
%
62.2
58.2
0.88
29
58
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
32
70
4.81
13.95
1.8
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
301
2096
2.04
13.92
8.7
6.3
umol/l
10.1
11.2
1.78
290
1974
(3042936) Bacteria identified in Isolate by Culture
105
484
2.47
13.91
3.0
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
48
5.65
13.67
1.5
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
28
56
5.23
13.51
4.8
2.8
e9/l
4.5
4.2
0.32
28
56
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
158
883
2.14
13.19
1.3
1.2
u/ml
0.9
1.9
0.93
33
222
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
95
431
2.48
12.97
2.2
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
106
3.90
12.89
5.7
5.3
mg/l
34.2
30.6
0.15
32
93
(3027945) Reticulocytes/100 erythrocytes in Blood
91
406
2.51
12.87
2.8
2.4
%
1.8
1.8
0.10
84
373
(44790048)
24
44
5.67
12.70
2.0
1.5
—
—
—
0
0
(44790049)
24
44
5.67
12.70
2.0
1.5
—
—
—
0
0
(44790047)
24
44
5.67
12.70
2.0
1.5
—
—
—
0
0
(44806118)
24
44
5.67
12.70
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
63
238
2.88
12.34
6.0
4.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
24
46
5.42
12.12
1.4
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
106
3.79
12.12
5.9
5.3
mg/l
45.1
49.8
0.13
32
92
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
25
51
5.10
11.80
1.0
1.2
u/ml
3.0
7.0
0.32
11
13
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
51
5.10
11.80
1.4
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
571
2.23
11.63
1.8
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
31
78
4.16
11.37
2.1
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
67
275
2.65
11.19
2.1
1.5
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
89
418
2.36
11.18
13.5
7.0
kpa
10.5
12.5
3.97
79
403
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
89
418
2.36
11.18
13.6
7.0
kpa
5.2
5.0
0.59
79
401
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
70
296
2.58
11.01
2.9
2.4
ug/l
18.4
6.8
2.35
61
258
(3031040) Bacteria [#/volume] in Urine by Automated count
341
2593
1.93
11.01
6.4
4.0
e6/l
15.4
2600.4
—
5
42
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
133
741
2.07
10.93
6.1
3.9
ng/l
235.1
289.6
0.21
115
575
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
55
4.73
10.82
2.0
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
51
4.89
10.82
2.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
13
14
9.50
10.80
1.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
36
5.74
10.77
1.1
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
124
680
2.08
10.60
1.8
1.7
nmol/l
1125.6
1225.0
0.61
101
510
(3003396) Base excess in Arterial blood by calculation
87
416
2.31
10.45
13.8
7.0
mmol/l
1.5
1.0
0.38
66
326
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
57
4.56
10.37
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
236
1618
1.84
10.35
3.5
2.6
ug/l
194.5
126.5
1.94
224
1485
(3037692) Legionella sp identified in Specimen by Organism specific culture
13
15
8.86
10.27
2.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
75
4.04
10.26
5.9
6.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
24
6.85
10.23
1.1
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
187
1196
1.88
10.19
3.1
3.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
230
1582
1.82
9.84
10.2
8.2
inr
1.2
1.2
0.10
59
471
(3015377) Calcium [Moles/volume] in Serum or Plasma
204
1357
1.83
9.71
3.6
3.7
mmol/l
2.3
2.4
2.46
188
1199
(3013826) Glucose [Moles/volume] in Serum or Plasma
305
2290
1.81
9.67
9.0
4.4
mmol/l
6.6
6.7
0.56
293
2154
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
109
3.37
9.49
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
21
45
4.82
9.37
1.2
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
46
4.72
9.14
1.5
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
86
435
2.17
8.97
1.9
2.2
ug/g
192.1
122.9
0.64
73
339
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
51
4.46
8.95
1.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
149
918
1.88
8.93
1.7
1.5
nmol/l
19.7
20.8
0.47
132
765
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
40
4.89
8.65
2.3
2.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
109
611
1.99
8.63
3.9
2.6
e6/l
3.4
2.4
0.63
68
326
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
49
4.42
8.48
1.7
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
45
4.58
8.43
1.7
1.7
—
—
—
0
0
(4062490)
16
30
5.47
8.25
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
30
5.47
8.25
1.3
1.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
152
964
1.82
8.21
6.8
3.7
%
91.2
91.4
0.04
146
947
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
55
4.13
8.15
1.0
1.2
u/ml
2.4
4.8
—
8
24
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
133
811
1.86
8.15
2.2
1.6
mg/l
1.2
1.2
0.13
100
616
(3044941) Cell count panel - Synovial fluid
12
17
7.20
8.02
1.3
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
35
4.99
7.93
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
35
4.99
7.93
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
213
1501
1.71
7.92
5.2
3.3
ng/l
95.6
65.5
0.47
180
1019
(3036489) Thrombin time
36
128
2.95
7.86
3.0
2.0
s
21.6
21.6
0.01
31
114
(3016502) Oxygen saturation in Arterial blood
74
372
2.15
7.81
15.7
7.4
%
94.6
95.7
0.73
67
361
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
46
189
2.57
7.65
18.4
9.0
mmol/l
24.6
24.4
0.16
41
181
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
6
18.69
7.63
1.6
2.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
33
116
2.97
7.36
3.0
2.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
63
304
2.22
7.35
17.9
7.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
181
1240
1.71
7.34
2.7
2.3
u/l
54.4
57.1
0.50
168
1129
(3029937) Albumin [Presence] in Urine by Test strip
153
1001
1.75
7.32
6.6
3.4
estimate
0.0
0.0
0.80
64
333
(3023520) Reticulocytes [#/volume] in Blood
60
287
2.23
7.14
2.7
2.5
e9/l
69.4
71.9
0.18
43
210
(3023419) Bacteria identified in Sputum by Culture
19
47
4.16
7.14
2.4
2.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
83
451
2.00
7.10
3.4
2.8
umol/l
6.7
8.9
0.85
70
392
(3017732) Neutrophils [#/volume] in Blood
51
228
2.37
7.10
3.7
2.4
e9/l
3.7
4.1
0.54
40
185
(3041096) Erythrocytes [Presence] in Urine by Automated
158
1052
1.72
7.06
4.5
3.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
43
4.30
7.06
2.2
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
39
4.47
7.01
1.2
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
31
4.95
6.97
2.5
3.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
31
4.95
6.97
1.1
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
8
14.01
6.91
1.9
1.4
ug/l
8.4
9.0
—
11
8
(3026782) Osmolality of Urine
124
777
1.78
6.83
3.5
2.6
mosm/kgh2o
556.4
548.4
0.14
111
659
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
17
6.59
6.80
1.7
3.6
u/ml
1187.1
1198.9
0.01
11
17
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
216
1580
1.63
6.66
2.2
1.9
pmol/l
95.0
94.7
0.03
120
777
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
95
3.06
6.64
5.0
2.5
u/ml
0.4
0.4
0.05
19
56
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
202
1456
1.64
6.59
6.0
3.6
—
—
—
0
0
(4306422)
19
51
3.83
6.42
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
15
6.78
6.33
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
15
6.78
6.33
1.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
43
4.05
6.21
4.9
4.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
116
2.78
6.20
1.4
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
94
2.98
6.14
1.2
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
19
5.89
6.13
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
39
4.20
6.13
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
39
4.20
6.13
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
39
4.20
6.13
1.5
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
117
2.75
6.10
1.4
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
36
147
2.56
6.09
1.9
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
450
4011
1.94
6.09
32.1
12.2
mg/l
19.6
25.1
4.36
417
3045
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
13
27
4.91
6.00
2.2
1.7
mg/l
2.7
2.5
0.23
13
27
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
6
15.23
5.92
1.1
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
77
434
1.91
5.90
28.5
22.6
inr
1.9
1.2
—
7
51
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
80
3.10
5.88
2.5
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
9
11.30
5.81
1.7
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
55
3.55
5.78
1.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
42
189
2.33
5.78
2.1
2.4
—
—
—
0
0
(4268621)
16
41
4.00
5.75
1.8
2.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
115
2.71
5.75
1.3
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
90
539
1.81
5.70
1.3
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
7
13.05
5.60
4.8
3.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
60
317
2.01
5.54
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
25
4.89
5.52
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
5
16.23
5.42
1.0
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
13
30
4.42
5.32
2.8
2.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
30
4.42
5.32
1.5
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
180
2.26
5.08
4.6
3.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
27
4.53
5.06
1.1
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
9
10.15
5.04
1.0
1.0
iu/ml
90.7
297.4
—
9
9
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
32
137
2.42
4.93
2.7
1.9
—
—
—
0
0
(3020891) Body temperature
31
131
2.45
4.91
7.9
4.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
24
4.66
4.80
1.0
1.1
nmol/l
0.1
0.3
—
5
5
(3009871) Measles virus Ab [Titer] in Serum
9
10
9.13
4.80
1.3
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
43
212
2.12
4.78
1.6
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
62
350
1.88
4.73
18.3
7.6
g/l
120.7
121.2
0.07
57
340
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
218
1698
1.49
4.63
5.0
3.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
44
222
2.07
4.61
2.0
1.7
—
—
—
0
0
(3012501) Base excess in Blood by calculation
20
70
2.93
4.54
9.2
4.3
mmol/l
2.8
2.7
0.07
15
54
(3019150) Specific gravity of Urine by Refractometry
118
807
1.60
4.53
6.9
3.4
kg/l
1.0
1.0
0.48
19
113
(1616796) Gas panel - Central venous blood
21
76
2.84
4.50
5.0
2.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
53
290
1.92
4.44
6.1
2.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
63
366
1.82
4.39
2.3
2.3
u/l
367.4
37.2
0.49
54
307
(1761868) Lipid panel - Serum or Plasma
106
1501
0.63
4.30
2.8
2.9
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
9
9.01
4.29
1.3
2.0
—
—
—
0
0
(3000492) Spirometry study
61
358
1.80
4.12
2.4
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
58
3.00
4.04
2.9
3.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
14
6.52
4.00
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
72
449
1.70
3.94
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
200
2.03
3.94
1.4
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
111
773
1.56
3.90
2.4
3.0
mmol/l
2.5
2.5
0.77
94
689
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
11
7.37
3.87
1.1
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
42
223
1.96
3.86
11.7
6.5
mmol/l
24.9
24.3
0.40
37
211
(3037121) Protein [Mass/volume] in Urine
28
127
2.27
3.84
2.6
3.1
g/l
0.3
0.3
—
10
51
(3019225) pH of Specimen
63
382
1.74
3.82
7.3
4.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
39
3.39
3.78
1.6
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
55
2.97
3.77
1.1
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
59
354
1.75
3.71
6.2
3.4
mmol/l
2.1
1.8
0.30
51
283
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
91
2.48
3.69
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
91
2.48
3.69
1.4
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
8
12
6.75
3.68
2.3
1.2
u/l
35.8
89.0
—
8
12
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
12
6.75
3.68
1.1
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
9
17
5.37
3.52
1.7
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
13
6.23
3.51
1.0
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
8
13
6.23
3.51
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
126
2.21
3.48
2.5
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
308
2648
1.40
3.46
4.1
2.9
u/l
55.4
47.5
0.89
295
2455
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
203
1.94
3.45
24.4
9.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
114
821
1.50
3.41
1.6
1.7
pmol/l
65421004.9
11027631.6
0.38
107
662
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
27
3.76
3.37
1.5
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
150
1145
1.44
3.32
2.9
2.3
—
—
—
0
0
(4027681)
9
19
4.80
3.25
1.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
19
4.80
3.25
1.0
1.1
—
—
—
0
0
(4015189)
7
11
6.43
3.19
1.3
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
44
3.00
3.15
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
34
3.28
3.07
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
45
2.94
3.04
3.4
2.2
%
90.5
89.3
0.51
13
45
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
5
10.08
2.98
3.8
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
5
10.08
2.98
1.0
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
25
121
2.12
2.98
7.8
6.9
mmol/l
1.2
1.3
0.26
17
104
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
17
4.76
2.93
1.5
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
31
3.27
2.78
1.0
1.1
mg/l
304.0
283.8
—
10
25
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
125
2.05
2.75
1.6
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
14
5.05
2.73
1.1
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
856
1.43
2.72
2.8
2.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
7
7.20
2.55
2.0
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
11
5.50
2.55
5.2
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
33
3.07
2.54
1.2
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
33
3.07
2.54
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
33
3.07
2.54
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
22
3.68
2.37
1.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
22
3.68
2.37
1.3
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
17
4.16
2.36
1.7
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
17
4.16
2.36
1.7
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
17
4.16
2.36
1.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
19
91
2.13
2.35
2.1
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
119
1.98
2.34
1.3
1.5
ug/g
295.1
282.1
0.11
15
73
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.52
2.28
1.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.52
2.28
1.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.52
2.28
1.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.52
2.28
1.6
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
211
1.71
2.23
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
9
5.60
2.22
2.0
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
9
5.60
2.22
2.6
6.2
%
55.6
42.0
—
5
9
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
220
1.68
2.19
3.2
3.1
pmol/l
4.2
4.5
1.61
30
191
(3047189) Immunofixation for 24 hour Urine
7
19
3.72
2.15
3.4
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
30
3.03
2.15
2.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
14
4.32
2.15
1.2
1.2
nmol/l
157.7
167.9
—
6
14
(4211845)
6
14
4.32
2.15
5.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
351
0.52
2.09
1.7
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
201
1.69
2.04
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
397
1.49
2.02
5.3
3.0
—
—
—
0
0
(4010399)
46
307
1.55
1.98
2.1
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
77
2.11
1.98
1.6
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
21
3.36
1.97
1.6
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
21
3.36
1.97
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.58
1.94
1.2
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
58
2.27
1.92
1.2
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
341
3114
1.28
1.90
4.8
3.8
pmol/l
15.0
14.8
0.75
318
2802
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
10
40
2.53
1.84
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
17
3.56
1.84
2.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
17
3.56
1.84
2.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
80
2.03
1.82
1.4
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
74
2.06
1.76
1.9
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
18
3.36
1.75
2.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
18
3.36
1.75
1.0
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
36
2.53
1.74
3.6
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
191
1641
1.26
1.74
2.5
2.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
13
3.87
1.72
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
13
3.87
1.72
1.0
1.1
miu/ml
1323.8
1056.5
—
5
13
(3012516) Albumin [Mass/volume] in Urine
138
1145
1.28
1.67
3.3
3.1
mg/l
2368.4
175.1
1.46
97
701
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
25
2.82
1.65
1.6
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
397
3724
1.28
1.62
5.6
4.6
mu/l
1.9
2.2
0.47
375
3376
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
99
1.85
1.59
1.4
1.6
iu/l
3.8
5.1
—
7
32
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
64
2.06
1.55
1.5
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
72
1.97
1.50
3.2
2.0
g/l
114.0
133.1
—
7
54
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
109
1.77
1.48
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
143
1208
1.25
1.48
3.2
3.0
mmol/l
6.7
7.4
1.13
124
1009
(3003327) Ova and parasites identified in Stool by Light microscopy
20
117
1.74
1.47
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
237
1.51
1.46
3.2
3.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
38
2.39
1.46
1.1
1.0
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
16
3.14
1.44
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
13
237
0.54
1.42
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
22
134
1.67
1.41
1.3
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
40
2.27
1.40
4.0
3.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
383
4038
0.80
1.38
4.9
4.3
mmol/l
1.4
1.5
4.12
360
3691
(3017704) Immunofixation for Urine
6
23
2.63
1.37
2.2
2.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
42
2.16
1.34
1.2
1.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
40
285
1.44
1.32
2.8
2.8
ml/min/173m2
72.8
68.8
0.13
12
121
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
387
4069
0.81
1.31
4.9
4.3
mmol/l
4.8
4.7
1.33
363
3746
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
368
3889
0.81
1.31
4.6
3.9
mmol/l
1.5
1.3
4.22
346
3530
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
24
2.52
1.30
2.5
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
24
2.52
1.30
2.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
261
1.45
1.29
1.5
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
44
2.06
1.27
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
35
2.31
1.27
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
25
2.42
1.24
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
45
2.02
1.24
1.6
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
37
2.18
1.22
1.9
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
30
2.35
1.12
2.1
1.3
g/l
1.0
1.0
—
7
30
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
58
458
1.30
1.05
2.5
4.3
ug/l
3.0
41.8
1.46
46
385
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
34
2.07
1.03
2.1
3.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
83
1.71
1.02
1.1
1.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.8
1.4
—
—
—
0
0
(4146454)
7
35
2.01
1.00
1.7
2.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
76
1.73
0.99
4.2
2.1
%
15.2
16.8
—
5
37
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
452
4375
1.26
0.99
25.4
9.1
u/l
31.2
25.6
7.33
445
4193
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
49
1.85
0.99
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
49
1.85
0.99
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
49
1.85
0.99
1.8
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
84
1.69
0.98
3.0
3.7
mg/l
31.7
26.7
—
8
52
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
20.1
—
1741.6
—
0
30
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
398
4140
0.83
0.97
5.2
4.8
mmol/l
2.9
2.8
1.73
376
3788
(3016018) Differential panel - Cerebral spinal fluid
7
36
1.96
0.97
2.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
50
1.81
0.97
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
50
1.81
0.97
1.8
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
437
4217
1.23
0.96
30.5
14.6
mmol/l
139.3
139.7
2.28
427
4078
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
77
1.71
0.96
1.1
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
30
2.01
0.87
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
64
1.73
0.86
3.6
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
437
4234
1.21
0.81
30.9
14.7
mmol/l
3.9
4.0
1.67
427
4089
(3007930) Methemoglobin/Hemoglobin.total in Blood
23
164
1.42
0.81
7.3
5.4
%
1.1
0.9
1.41
18
156
(3049717) Cytology report of Urine Cyto stain
9
147
0.61
0.80
2.4
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
303
2858
1.15
0.80
5.4
3.6
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
8.8
—
0
8
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
11.3
—
0.7
—
0
24
(3027944) Amphetamines [Presence] in Urine
7
125
0.55
0.78
1.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
125
0.55
0.78
1.3
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
135
1206
1.16
0.77
3.9
3.8
mg/mmol
7.2
9.8
0.45
85
740
(3013512) EKG study
130
1159
1.16
0.76
4.3
3.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
16
108
1.50
0.74
9.8
2.8
mmol/l
3.9
3.9
0.00
16
102
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
403
3889
1.16
0.73
24.9
11.8
ml/min/173m2
85.8
80.9
3.69
359
3133
(3005570) Glucose [Moles/volume] in Urine
7
40
1.76
0.71
2.0
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
76
653
1.19
0.69
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
54
449
1.23
0.68
1.4
1.8
%
1.5
1.4
0.16
43
393
(1761482) Bacteria [#/volume] in Urine by Culture
7
117
0.59
0.68
2.4
5.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
28
361
0.76
0.68
1.3
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
86
1.52
0.66
11.5
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
438
4266
1.17
0.64
24.3
11.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
63
1.60
0.62
1.2
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
30
1.67
0.61
2.0
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.6
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
50
1.61
0.61
1.0
1.3
—
—
—
0
0
(44813793)
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
80
1.51
0.60
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
116
0.60
0.58
1.0
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
40
329
1.23
0.58
1.3
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
35
1.72
0.58
2.0
2.4
%
13.7
13.0
—
6
35
(3002256) Pathology report gross observation
62
534
1.18
0.57
1.4
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
8
55
1.46
0.56
1.0
1.3
nmol/l
—
0.9
—
0
6
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
22
168
1.32
0.56
7.5
5.3
%
2.0
1.6
1.83
17
159
(3027008) Opiates [Presence] in Urine
8
126
0.63
0.55
1.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
126
0.63
0.55
1.0
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
126
0.63
0.55
1.0
1.7
—
—
—
0
0
(1002224) Polysomnography panel
22
169
1.32
0.54
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
17
127
1.35
0.50
2.0
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
67
1.50
0.50
4.3
2.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
45
1.56
0.49
1.6
1.8
pg
33.1
31.9
—
7
45
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
321
0.80
0.48
2.7
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
41
347
1.20
0.47
5.8
3.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.0
1.3
nmol/l
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
85
0.58
0.45
1.0
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
149
1.29
0.42
1.6
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
5
36
1.39
0.38
7.4
7.2
mmol/l
6.8
7.2
—
5
30
(3012441) Differential panel - Pleural fluid
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
68
1.33
0.37
1.0
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
6
42
1.43
0.35
2.2
2.1
—
13.4
—
0
11
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
30
255
1.19
0.35
1.3
1.2
iu/ml
96.1
124.5
—
8
100
(40768795) Lymph node Pathology biopsy report
6
45
1.34
0.34
1.3
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
47
1.28
0.32
2.2
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
107
0.74
0.29
1.5
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
367
3745
0.93
0.29
34.7
13.7
%
39.2
39.9
0.70
255
2652
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
118
1111
1.08
0.29
4.7
4.9
ug/l
3.9
2.9
0.40
107
995
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
63
1.27
0.28
6.1
2.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
23
196
1.18
0.27
2.2
4.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
248
2401
1.06
0.27
3.1
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
75
0.66
0.26
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
383
3762
1.07
0.26
6.3
5.5
mmol/mol
40.1
39.8
0.22
364
3454
(4034850)
15
123
1.23
0.25
23.7
9.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
119
1129
1.07
0.24
1.6
1.6
mmol/l
1.6
1.4
1.94
102
938
(40768806) Pleura Pathology biopsy report
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
111
0.81
0.20
1.1
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
49
1.23
0.20
2.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
86
907
0.94
0.19
3.6
4.3
%
22.4
21.8
0.18
43
431
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
393
3977
0.95
0.17
5.0
4.4
mmol/l
5.7
5.9
3.38
366
3604
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
68
0.73
0.17
1.0
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
33
360
0.91
0.16
2.5
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
274
1.10
0.15
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
17
192
0.88
0.15
2.1
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
55
519
1.07
0.14
4.9
4.2
%
30.1
31.8
0.65
42
331
(3008898) HLA-B27 [Presence]
10
85
1.18
0.12
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
51
483
1.06
0.12
9.1
6.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
115
1.13
0.10
1.8
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
69
664
1.05
0.10
2.7
2.9
ug/l
0.7
0.8
0.27
48
437
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
45
1.11
0.10
1.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
75
0.80
0.07
1.8
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
458
4561
1.04
0.07
43.6
18.2
e9/l
261.5
250.0
2.07
452
4412
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
177
1.08
0.06
2.1
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
458
4565
1.03
0.05
43.6
18.2
e12/l
4.4
4.5
6.75
451
4406
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
140
1.07
0.04
2.1
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
458
4566
1.03
0.04
43.6
18.2
e9/l
7.0
6.6
2.59
451
4408
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
676
1.02
0.04
1.6
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
109
1079
1.01
0.02
1.4
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
41
418
0.98
0.01
1.6
1.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
49
1.02
0.00
1.4
1.4
u/l
31.3
31.8
—
5
40
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
1.5
—
0
8
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.4
—
0
6
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
34.4
—
0
7
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.0
—
96.6
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
69
1.01
0.00
1.4
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.0
—
1.2
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
64
0.94
0.00
1.2
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
54
0.93
0.00
1.6
1.3
mmol/l
7.8
7.6
—
5
35
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint DERMATOPOLY_FG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DERMATOPOLY_FG | 2.299 [1.97, 2.68] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.13 |
During the follow-up period (1.1.1998 — 31.12.2019), 396 out of 1305 females with DERMATOPOLY_FG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| DERMATOPOLY_FG | 2.482 [2.06, 3.0] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 296 out of 812 males with DERMATOPOLY_FG died.
Mortality risk
Mortality risk for people of age
years, who have DERMATOPOLY_FG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.186% | 0.452% |
| 5 | 1.199% | 2.697% |
| 10 | 3.158% | 6.784% |
| 15 | 5.816% | 11.73% |
| 20 | 10.511% | 19.65% |
Relationships between endpoints
↥Index endpoint: DERMATOPOLY_FG – Dermatopolymyositis (FG)
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data